RSS

biologics

New technologies such as artificial intelligence (AI) could revolutionise pharmaceutical manufacturing but only if regulators change to prevent hindering future innovation. Read more

News

Justin Schroeder, vice president for global programme management at PCI Pharma Services, looks at how to support the delivery of biologics through automated inspection systems. Read more

Opinion

Stéphane Varray - commercial development - head of Launch for Mammalian and Microbial, Development & Manufacturing at Lonza discusses trends in biomanufacturing and the innovation occurring in the sector. Read more

Opinion

India’s biologic market is set for strong growth in 2019 according to new data from CPhI. Read more

News

Jonathan Wilkins, marketing director of obsolete industrial parts supplier EU Automation, explains how biopharmaceutical plants can benefit from automation. Read more

Opinion

Technology group Fujifilm will acquire a large-scale biologics manufacturing site from biotech player Biogen for approximately $890 million, the company has announced. Read more

News

Smaller companies are expected to drive innovation across Europe, according to the latest report from Pharmapack. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData Read more

Opinion

Here, Rich Quelch, global head of marketing, Origin, looks at the challenges involved in primary packaging and delivery systems for biologics. Read more

Opinion

Science and technology company, Merck, has entered into a cooperation agreement with Netherlands-based InnoCore Pharmaceuticals, for a new drug delivery platform that will aim to improve patient compliance. Read more

News

The recently announced ‘Biosimilar Action Plan’ (BAP) from the US Food and Drug Administration (FDA) is another move by the regulatory body to achieve cost-effective pricing, according to an analyst at data and analytics company, GlobalData. Read more

News

iBio, has established a strategic commercial relationship with specialist in plant molecular medicine technology research and product development, CC-Pharming, for the joint development of products and manufacturing facilities in China. Read more

News

Here, Tony Hitchcock, technical director at Cobra Biologics and Joanne Anderson, business development director at Symbiosis, discuss the challenges associated with manufacturing for gene therapies. Read more

, Opinion

Here, Steve Lyon, digital lead, Communities & Content, Allied Market Research (AMR), discusses some examples of new technology in the ADC space and the ground-breaking potential this new class of drugs will have in the treatment of cancer Read more

Opinion

The National Institute for Health and Care Excellence (NICE) has published its positive guidance for the first selective interleukin (IL)-23 inhibitor to treat moderate to severe plaque psoriasis. Read more

News

The June issue of EPM magazine is available for download with all the regulars and features on biologics, solid dosage solutions, Queen’s Awards, purification & filtration, packaging, logistics & distribution. Read more

Latest Issue

Biopharmaceutical company, Bioasis, and Hong-Kong based biologics company, WuXi Biologics, have announced an initial strategic collaboration for the development and manufacture of xB3-001 — a candidate for the treatment of brain cancer. Read more

News

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions, and Valerius Biopharma, a Swiss biopharmaceutical company, are collaborating on the development and manufacture of speciality biosimilars Read more

News

Biosimilar entry onto US market is slow despite implementation of the Biologics Price Competition and Innovation Act (BPCIA) by the Food and Drug Administration (FDA), according to data and analytics company, GlobalData. Read more

Analysis